Anastrozole as Neoadjuvant Therapy for Patients with Hormone-dependent, Locally-advanced Breast Cancer

Anticancer Research

Volumn 24, Issue 2 C, 2004, Pages 1315-1318

  Milla Santos, A ^a   Milla, L ^c   Calvo, N ^c   Portella, J ^b   Rallo, L ^a   Casanovas, J M ^a   Pons, M ^b   Rodes, J ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b Service of Obstetrics and Gynecology   (Spain)

^c HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

Anastrozole; Breast cancer; Hormone dependent tumors; Postmenopausal

Indexed keywords

ANASTROZOLE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SURGERY; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FLUID RETENTION; HORMONE DEPENDENCE; HOT FLUSH; HUMAN; LEUKORRHEA; MAJOR CLINICAL STUDY; MASTECTOMY; OPEN STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; SIDE EFFECT; SOMNOLENCE; SWEATING; TREATMENT OUTCOME; VAGINA BLEEDING;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASMS, HORMONE-DEPENDENT; NITRILES; TRIAZOLES;

EID: 2442439027     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Miller WR, Anderson T, Hawkins RA, Keen J and Dixon JM: Neoadjuvant endocrine treatment: the Edinburgh experience. In: Howell A, Dowsett M (eds) Primary Medical Therapy for Breast Cancer. ESO Scientific Updates vol. 4. Elsevier, Amsterdam, 1999, pp 1-11.
2. Bergman L, van Dongen JA, van Ooijen B and van Leeuwen FE: Should tamoxifen be a primary treatment choice for elderly breast cancer patients with locoregional disease? Breast Cancer Res Treat 34: 77-83, 1995.
3. Gazet JC, Ford HT, Coombes RC, Bland JM, Sutcliffe R, Quilliam J and Lowndes S: Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer. Eur J Surg Oncol 20: 207-214, 1994.
4. Van Dalsen AD and De Vries J: Treatment of breast cancer in elderly patients. J Surg Oncol 60: 80-82, 1995.
5. Allan SG, Rodger A, Smyth JF, Leonard RC, Chetty U and Forrest AP: Tamoxifen as primary treatment of breast cancer in elderly or frail patients: a practical management. Br Med J 29: 358-362, 1985.
6. Dixon JM: Neoadjuvant endocrine therapy. In: Miller WR, Santen RJ (eds): Aromatase Inhibition and Breast Cancer. Marcel Dekker Inc, New York, 2001, pp 103-116.
7. Leal da Silva JM, Cardoso F, Oliveira F, Cunha H and Pinto Ferreira E: Neoadjuvant hormonal therapy in locally advanced breast cancer. Eur J Cancer 34: S15 (abstract 52), 1998.
8. Gershanovich M, Chaudri HA, Campos D, Lurie H, Bonaventura A, Jeffrey M, Buzzi F, Bodrogi I, Ludwig H, Reichardt P, O'Higgins N, Romieu G, Friederich P and Lassus M: Letrozole, a new aromatase oral inhibitor: randomized trial comparing 2.5 mg daily with 0.5 mg daily and aminogluthetimide in postmenopausal women with advanced breast cancer. Ann Oncol 16: 453-461, 1998.
9. Hamilton A and Piccart M: The third generation non-steroidal aromatase inhibitors: a review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer. Ann Oncol 10: 377-384, 1999.
10. Buzdar AU, Jonat W, Howell A, Jones SE, Blomqvist CP, Vogel CL, Eiermann W, Wolter JM, Steinberg M, Webster A and Lee D: Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Cancer 83: 1142-1152, 1998.
11. Dixon JM, Renshaw L, Bellamy C, Stuart M, Hoctin-Boes G and Miller WR: The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study. Clin Cancer Res 6: 2229-2235, 2000.
12. Milla-Santos A, Milla L, Rallo L and Solano V: Anastrozole versus tamoxifen as first-line therapy in postmenopausal patients with hormone-dependent advanced breast. Am J Clin Oncol 26(3): 317-322, 2003.
13. Miller AM, Hoogstraten B, Staquet M and Winkler A: Reporting results of cancer treatments. Cancer 47: 207-214, 1981.
14. Kenny FS, Robertson JFR, Ellis IO, Elston CW and Blamey RW: Primary tamoxifen versus mastectomy and adjuvant tamoxifen in fit elderly patients with operable breast cancer of high ER content. Breast 8: 216-221, 1999.
15. WHO Adverse Reactions Dictionary: WHO Collaborating Center for International Drug Monitoring. Uppsala, Sweden. 1988.
16. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
17. Ciatto S, Cirillo A, Confortini M and Cardillo C de. L: Tamoxifen as primary treatment of breast cancer in elderly patients. Neoplasma 43: 43-45, 1996.
18. Miller WR, Dixon JM, Cameron DA and Anderson TJ: Biological and clinical effects of aromatase inhibitors in neoadjuvant therapy. J Ster Biochem Mol Biol 79: 103-107, 2001.
19. Gianni L, Valagussa P, Zambetti M, Molitemi A, Capri G and Bonadonna G: Adjuvant and neoadjuvant treatment of breast cancer. Semin Oncol 28: 13-29, 2001.
20. Bonneterre J, Buzdar A, Nabholtz JM, Robertson JFR, Thürlimann B, von Euler M, Sahmoud T, Webster A, Steinberg M, Arimidex Writing Committee and Investigators Committee Members: Anastrozole ('Arimidex') is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast cancer: results of two randomized trials designed for combined analysis. Cancer 92(9): 2247-2258, 2001.
21. Hoff PM, Valero V, Buzdar AU, Singletary SE, Theriault RL, Booser D, Asmar L, Frye D, McNeese MD and Hortobagyi GN: Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy. Cancer 88: 2054-2060, 2000.
22. Bradbeer J: Treatment of primary breast cancer in the elderly with "Novaldex" alone. Rev Endoc-Relat Canc 16: 39-42, 1985.
23. Dixon JM, Love CDB, Tucker S, Bellamy D, Cameron D, Miller WR and Leonard RC: Letrozole as primary medical therapy for locally advanced and large operable breast cancer (abstract). Proc ASCO 17: 104, 1998.
24. Eiermann W, Paepke S, Appfelstaedt J, Llombart-Cussac A, Eremin J, Vinholes J Mauriac L, Ellis M, Lassus M, Chaudri-Ross HA, Dugan M and Borgs M: Preoperative treatment of postmenopausal breast cancer patients with letrozole. A randomized double-blind multicenter study. Annals Oncol 12 (11): 1572-1532, 2001.